NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 378 filers reported holding NOVAVAX INC in Q1 2022. The put-call ratio across all filers is 1.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $125,572 | -34.5% | 18,120 | -2.8% | 0.00% | – |
| Q4 2022 | $191,568 | -42.3% | 18,635 | +2.2% | 0.00% | – |
| Q3 2022 | $332,000 | -64.9% | 18,240 | -0.9% | 0.00% | – |
| Q2 2022 | $947,000 | +46.1% | 18,406 | +109.2% | 0.00% | – |
| Q1 2022 | $648,000 | -33.9% | 8,800 | +85.9% | 0.00% | – |
| Q3 2021 | $981,000 | -50.5% | 4,734 | -49.3% | 0.00% | -100.0% |
| Q2 2021 | $1,983,000 | -37.2% | 9,341 | -46.4% | 0.00% | 0.0% |
| Q1 2021 | $3,160,000 | +45.1% | 17,428 | -10.8% | 0.00% | 0.0% |
| Q4 2020 | $2,178,000 | +1.9% | 19,534 | -1.0% | 0.00% | 0.0% |
| Q3 2020 | $2,138,000 | – | 19,732 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |